Anti-BCL2 (clone W24V44) Recombinant Antibody Coupled Liposome (VS-1024-FY47) (CAT#: VS-1024-FY47)
Anti-BCL-2 antibody conjugated liposomes are targeted therapeutic agents that was designed to specifically deliver treatment to B-cell malignancies by binding to the BCL-2 protein. They aim to enhance the apoptotic response in cancer cells by overcoming the protective effects of BCL-2 overexpression, which is linked to poor prognosis and treatment resistance. This approach, along with other therapeutic strategies such as BCL-2 inhibitors and siRNA, seeks to improve treatment outcomes for patients with B-cell leukemias and lymphomas.
Anti-Bcl-2 antibody-conjugated liposomes have demonstrated significant therapeutic potential in ischemic myocardial studies. By targeting the Bcl-2 protein, these liposomes can effectively regulate apoptosis in cardiomyocytes and mitigate damage caused by myocardial ischemia. Their application in vivo can enhance the targeting and bioavailability of drugs, thereby improving therapeutic efficacy. This innovative drug delivery method offers new insights and hope for the treatment of cardiovascular diseases.
More Infomation
Subcellular Location
Normal Tissue
RNA Expression
Figure 1 IF staining of human cell line SK-MEL-30
(Immunofluorescent staining of human cell line SK-MEL-30 shows localization to nucleoplasm & nuclear membrane.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/55295/1484_G3_6_selected.jpg
(Immunofluorescent staining of human cell line SK-MEL-30 shows localization to nucleoplasm & nuclear membrane.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/55295/1484_G3_6_selected.jpg
Figure 2 Thyroid gland
(Glandular cells
Staining: High
Intensity: Strong
Quantity:>75%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3/155167_B_3_5.jpg
(Glandular cells
Staining: High
Intensity: Strong
Quantity:>75%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3/155167_B_3_5.jpg
Figure 3 Colon
(Mucosal lymphoid cells
Staining: High
Intensity: Strong
Quantity: 75%-25%
Peripheral nerve/ganglion
Staining: High
Intensity: Strong
Quantity:>75%)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3/155167_A_7_3.jpg
(Mucosal lymphoid cells
Staining: High
Intensity: Strong
Quantity: 75%-25%
Peripheral nerve/ganglion
Staining: High
Intensity: Strong
Quantity:>75%)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3/155167_A_7_3.jpg
Figure 4 Kidney
(Cells in tubules
Staining: Medium
Intensity: Moderate
Quantity: 75%-25%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3/155167_A_8_5.jpg
(Cells in tubules
Staining: Medium
Intensity: Moderate
Quantity: 75%-25%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3/155167_A_8_5.jpg
Figure 5 Lymph node
(Germinal center cells
Staining: Medium
Intensity: Strong
Quantity: <25%
Location: Cytoplasmic/membranous
Non-germinal center cells
Staining: High
Intensity: Strong
Quantity:>75%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3/155167_A_7_8.jpg
(Germinal center cells
Staining: Medium
Intensity: Strong
Quantity: <25%
Location: Cytoplasmic/membranous
Non-germinal center cells
Staining: High
Intensity: Strong
Quantity:>75%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3/155167_A_7_8.jpg
Figure 6 RNA cell line category: Cell line enhanced (HDLM-2, HL-60, Karpas-707, U-266/70)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/ENSG00000171791-BCL2
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/ENSG00000171791-BCL2
Specifications
- Potential Clinical Applications
- B-cell malignancies, Ischemic myocardium in vivo
Product Composition
- Clone
- W24V44
- Antibody Type
- IgG
- Antibody Host
- Mouse
- Antibody Reactivity
- Human
- Antibody Description
- This product is a recombinant antibody derived from mouse antibodies that specifically targets the BCL-2 protein. BCL-2, or B-cell lymphoma 2, is a crucial regulatory protein that plays a significant role in controlling apoptosis, or programmed cell death, which is vital for maintaining cellular homeostasis and tissue health.
Product Property
- Storage
- See in the COA
- Storage Shelf Time
- See in the COA
Target Information
- Target
- BCL2
- Introduction
- This gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Alternative splicing results in multiple transcript variants.
- Alternative Names
- BCL2, Apoptosis Regulator; Protein Phosphatase 1, Regulatory Subunit 50; B-Cell CLL/Lymphoma 2; Apoptosis Regulator Bcl-2; PPP1R50; Bcl-2
- Full Name
- BCL2, Apoptosis Regulator
- Gene ID
- 596
- UniProt ID
- P10415
- Cellular Localization
- Cytoplasm, Endoplasmic reticulum, Membrane, Mitochondrion, Mitochondrion outer membrane, Nucleus
Related Resources
Hedgehog Signaling Pathway
p53 Signaling Pathway
Prostate Cancer
AGE-RAGE Signaling Pathway in Diabetic Complications
Amyotrophic Lateral Sclerosis
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "BCL2"
Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products
Fab Antibody Products
ScFv Antibody Products
Single Domain Antibody Products
Neutralizing Antibody Products
Rabbit Monoclonal Antibody Products
MHC Tetramer Products for Cancer
Antibody Magnetic Beads
Non-Human Primate (NHP) Antibody Products
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-103 | Recombinant Anti-dog BCL2 Antibody | ELISA, WB, FuncS | IgG |
| ZG-0047J | Mouse Anti-BCL2 Recombinant Antibody (clone 6B5) | IF/ICC, WB, IHC-P | Mouse IgG |
| ZG-0048J | Mouse Anti-BCL2 Recombinant Antibody (clone 2F1) | WB, IHC | Mouse IgG |
| VS4-WK47 | Mouse Anti-BCL2 Recombinant Antibody (clone 8E1D8) | ELISA, WB, FC | Mouse IgG1 |
| VS3-FY2632 | Mouse Anti-BCL2 Recombinant Antibody (VS3-FY2632) | WB | Mouse IgG |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-1024-FY47. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: ELISA
Application: ELISA, Neut, FuncS
Application: WB, IHC-Fr, IHC-P, ICC, IF
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
